Chronic False Positive Rapid Plasma Reagin (RPR) Tests Induced by COVID-19 Vaccination

COVID Pub Date : 2023-08-30 DOI:10.3390/covid3090090
E. Williams, Devin J. Kennedy, Michael E. Hoffer, J. M. Carreño, F. Krammer, S. Pallikkuth, S. Pahwa
{"title":"Chronic False Positive Rapid Plasma Reagin (RPR) Tests Induced by COVID-19 Vaccination","authors":"E. Williams, Devin J. Kennedy, Michael E. Hoffer, J. M. Carreño, F. Krammer, S. Pallikkuth, S. Pahwa","doi":"10.3390/covid3090090","DOIUrl":null,"url":null,"abstract":"False positive reactive plasmin reagin (RPR) reactivity following a COVID-19 vaccine has been reported, and it is therefore conceivable that individuals who receive frequent coronavirus disease 2019 (COVID-19) vaccinations may exhibit durable RPR responses. Here, we sought to investigate the extent to which repeated mRNA COVID-19 vaccines can elicit chronic false RPR reactivity in a longitudinal cohort. Participants (n = 119) in an IRB-approved (#20201026), longitudinal SARS-CoV-2 cohort study were screened for RPR reactivity via manual RPR card assays. Samples with reactive results underwent additional testing, including follow-on RPR screening at additional timepoints, confirmatory fluorescent treponemal antibody (FTA-ABS) testing and anti-nuclear antibody (ANA) testing. Medical histories were collected. We observed (n = 2) screen-positive RPR results (1.7% [2/119]) following booster vaccination, for which two individuals exhibited chronic, vaccine-induced RPR reactivity for up to 9 months following booster vaccination. Both participants were ANA-negative. It is imperative for clinicians to be mindful of the potential immunologic interference of COVID-19 vaccines with standard infectious disease assays, including RPR testing. Detailed medical histories and clinical contexts, including recent vaccination, should be reviewed prior to proceeding with distressing and invasive workups.","PeriodicalId":72714,"journal":{"name":"COVID","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"COVID","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/covid3090090","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

False positive reactive plasmin reagin (RPR) reactivity following a COVID-19 vaccine has been reported, and it is therefore conceivable that individuals who receive frequent coronavirus disease 2019 (COVID-19) vaccinations may exhibit durable RPR responses. Here, we sought to investigate the extent to which repeated mRNA COVID-19 vaccines can elicit chronic false RPR reactivity in a longitudinal cohort. Participants (n = 119) in an IRB-approved (#20201026), longitudinal SARS-CoV-2 cohort study were screened for RPR reactivity via manual RPR card assays. Samples with reactive results underwent additional testing, including follow-on RPR screening at additional timepoints, confirmatory fluorescent treponemal antibody (FTA-ABS) testing and anti-nuclear antibody (ANA) testing. Medical histories were collected. We observed (n = 2) screen-positive RPR results (1.7% [2/119]) following booster vaccination, for which two individuals exhibited chronic, vaccine-induced RPR reactivity for up to 9 months following booster vaccination. Both participants were ANA-negative. It is imperative for clinicians to be mindful of the potential immunologic interference of COVID-19 vaccines with standard infectious disease assays, including RPR testing. Detailed medical histories and clinical contexts, including recent vaccination, should be reviewed prior to proceeding with distressing and invasive workups.
COVID-19疫苗诱导的慢性假阳性快速血浆反应素(RPR)试验
据报道,在接种COVID-19疫苗后,反应性纤溶酶反应蛋白(RPR)反应性出现假阳性,因此可以想象,频繁接种2019冠状病毒病(COVID-19)疫苗的个体可能会表现出持久的RPR反应。在此,我们试图在纵向队列中研究重复mRNA COVID-19疫苗可在多大程度上引发慢性假RPR反应性。在irb批准的纵向SARS-CoV-2队列研究(#20201026)中,参与者(n = 119)通过人工RPR卡测定筛选RPR反应性。对反应性结果的样本进行额外的检测,包括在额外的时间点进行后续的RPR筛选、确认性荧光螺旋体抗体(FTA-ABS)检测和抗核抗体(ANA)检测。收集病史。我们观察到(n = 2)强化疫苗接种后RPR筛查阳性(1.7%[2/119]),其中2人在强化疫苗接种后表现出慢性疫苗诱导的RPR反应长达9个月。两名参与者均为ana阴性。临床医生必须注意COVID-19疫苗与标准传染病检测(包括RPR检测)的潜在免疫干扰。详细的病史和临床背景,包括最近的疫苗接种,应在进行痛苦和侵入性检查之前进行审查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信